Target General Information
Target ID T47415
Target Name HLA class I antigen B-7
Synonyms HLA class I histocompatibility antigen, B7 alpha chain; HLAB; MHC class I antigen B*7; HLA-B
Target Type Clinical Trial
Gene Name HLA-B
Biochemical Class MHC class I family
UniProt ID 1B07_HUMAN
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals
Disease Melanoma
Example drug Velimogene aliplasmid Phase 3 [521540], [1572592]
Tissue Skin
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual Fold-change: 1.11
Z-score: 1.21
P-value: 1.12E-04
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
Target Gene Expression Profiles in Other Tissues of Healthy Individuals
Reference
Ref 521540ClinicalTrials.gov (NCT00050388) Phase II Trial of Allovectin-7 for Head and Neck Cancer. U.S. National Institutes of Health.
Ref 1572592NCBI GEO: archive for functional genomics data sets--update.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.